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Abstract. One of the most important post-translational
modifications is represented by phosphorylation on tyrosine,
threonine and serine residues. Since abnormal phosphorylation
is associated with various pathologies, it was of interest to
perform a phosphoproteomic profiling of age-related skeletal
muscle degeneration. We used the fluorescent phospho-
specific Pro-Q Diamond dye to determine whether changes
in the overall phosphorylation of the soluble skeletal muscle
proteome differs significantly between young adult and
senescent fibres. As an established model system of sarcopenia,
we employed 30-month-old rat gastrocnemius fibres. Following
the mass spectrometric identification of 59 major 2-D
phosphoprotein landmark spots, the fluorescent dye staining
survey revealed that 22 muscle proteins showed a differential
expression pattern between 3-month- and 30-month-old
muscle. Increased phosphorylation levels were shown for
myosin light chain 2, tropomyosin α, lactate dehydrogenase,
desmin, actin, albumin and aconitase. In contrast, decreased
phospho-specific dye binding was observed for cytochrome c
oxidase, creatine kinase and enolase. Thus, aging-induced
alterations in phosphoproteins appear to involve the contractile
machinery and the cytoskeleton, as well as the cytosolic and
mitochondrial metabolism. This confirms that sarcopenia of
old age is a complex neuromuscular pathology that is
associated with drastic changes in the abundance and structure
of key muscle proteins.
Introduction
Since each mammalian gene may generate more than one
protein species, the approximately 30,000 human genes
probably express hundred thousands of different proteins (1).
Thus, proteomics research has a central place in modern
biology and biomedicine enabling us to understand the
enormously complex and dynamic protein expression patterns
in the various mammalian and human cell types (2-4). Since
post-translational modifications play a crucial role in protein
diversity, various sub-disciplines of proteomics have emerged
that focus on the cataloguing and functional characterization
of proteins with extensively modified site chains (5-7),
including phosphoproteins (8-12). Post-translational modifi-
cations are key modulators of protein structure, function,
signaling and regulation, whereby phosphorylation represents
one of the most frequent peptide modifications. Based on the
results of a recent mass spectrometric study, it can be assumed
that a large portion of proteins encoded by mammalian
genomes are phosphorylated at more than one residue (13).
Most phosphate groups are linked to the hydroxy group of
serine or threonine, in addition to tyrosine and various rare
amino acids (14). The biological importance of reversible
phosphorylation is emphasized by the large number of genes
encoding the protein families of protein kinases and
phosphatases (15,16). Complex co-operations between various
classes of kinases and phosphatases underlie the dynamics of
phosphorylation cycles, which are especially involved in
signaling pathways (17,18).
Over the last few years, skeletal muscle proteomics has
established itself as an important analytical tool for studying
normal and pathological aspects of modern myology (19-21).
Comprehensive proteomic maps exist for various species
including human skeletal muscle (22,23) and the most common
animals used in biomedical studies of neuromuscular diseases
(21,24,25). Recent mass spectrometry-based proteomic
profiling studies of skeletal muscle have revealed the protein
biochemical basis of important physiological processes, such
as the differential protein expression pattern in slow versus
fast fibers (26-28) and the stimulation-induced changes
during the fast-to-slow transition process (29,30). Proteomics
was instrumental in the establishment of new biomarkers of
myoblast differentiation (31) and muscle growth (32,33), as
well as the biochemical identification of disease markers that
are characteristic for X-linked muscular dystrophy (34,35),
dysferlinopathy (36) and immobilization-induced muscular
atrophy (37). Since aging also severely affects the performance
of skeletal muscle fibres (38), proteomics has been applied to
the investigation of the complex process of aging-induced
loss in skeletal muscle mass and function (39-42). 
Although proteomic studies on human muscle aging have
been successfully carried out (40), inter-individual differences
between patients make the interpretation of human proteomic
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data often difficult (43). In contrast, inbred animal strains
show genetically much less variations, therefore considerably
lower experimental repeats can produce meaningful patho-
biochemical results (21). Animal model proteomics can be
conveniently used to identify novel biomarkers of muscle
diseases and for studying basic mechanisms of molecular
pathogenesis. With respect to sarcopenia of old age, 30-month-
old rat skeletal muscle is a commonly employed model system
of aging-induced muscle wasting (44). Proteomic profiling of
senescent rat muscle has been performed with Coomassie
staining (39), fluorescent Deep Purple labeling (41) and
fluorescent difference in-gel electrophoresis (42). The main
findings of these studies agree with the idea that altered
protein expression occurs during aging in protein species that
are involved in contraction, metabolism, ion homeostasis and
stress response (38). In agreement with proteomic findings
(39-42), a recent cell biological study of major muscle stress
proteins has confirmed that the abundance of the small heat
shock proteins cvHsp/HspB5 and αB-crystallin/HspB7 is
greatly increased in aged muscle fibres (45), possibly
representing an auto-protective mechanism to extreme cellular
stress in senescent muscle (46).
Here, we used a combination of two-dimensional gel
electrophoresis, phospho-specific fluorescent Pro-Q Diamond
staining (47-51) and mass spectrometric analysis in order to
uncover potential age-dependent alterations in muscle protein
phosphorylation. Following the initial determination of
abundant 2-D gel electrophoretic landmark phosphoproteins
from the soluble skeletal muscle proteome, a quantitative
comparison of phosphoproteins in young adult versus old
muscle fibres was performed. The analysis revealed that 22
proteins appear to exhibit major changes in their phos-
phorylation moieties during muscle aging. Peptide mass
fingerprinting showed that members of this cohort of muscle
phosphoproteins belong to the contractile apparatus, the cyto-
skeletal network, major cytosolic pathways and mitochondrial
metabolism. Since altered phosphorylation patterns were
found in proteins involved in a great variety of biological
functions, it is reasonable to assume that these alterations in
post-translational modifications may be involved in the
functional decline of senescent fibres. 
Materials and methods
Materials. Pro-Q Diamond Phosphoprotein Gel Stain
(Molecular Probes, Eugene, OR, USA) was purchased from
BioSciences Ltd., Dun Laoghaire, Ireland. Electrophoresis
grade chemicals, immobilized pH gradient strips of pH 3.0-
10.0 and IPG buffer of pH 3.0-10.0 for isoelectric focusing,
the 2-D Quant kit and acetonitrile were from GE Healthcare
(Little Chalfont, Bucks, UK). Ultrapure Protogel acrylamide
stock solutions were from National Diagnostics (Atlanta,
GA, USA), and sequencing grade-modified trypsin was
obtained from Promega (Madison, WI, USA). A matrix kit
containing α-cyano-4-hydroxycinnamic acid and the external
peptide MS calibration kit Peptidemix-1 were from
Laserbiolabs (Sophia-Antipolis, France). Protease inhibitors
were purchased from Roche Diagnostics GmbH (Mannheim,
Germany). All other chemicals used were of analytical grade
and obtained from Sigma Chemical Co. (Dorset, UK). 
Preparation of protein extracts from skeletal muscle. The
phosphoproteomic study described here was performed with
3-month old versus 30-month-old rat gastrocnemius muscle
preparations, whereby 30-month-old Wister rats represent an
established animal model of sarcopenia of old age (39,41).
Freshly dissected tissue samples from young adult versus
senescent animals were obtained from the Bioresource Facility
of the Physiology Department, Trinity College Dublin. Rat
colonies were kept at a standard light dark cycle and fed ad
libitum (42). Both animal populations employed in this study
were not specifically trained, but were unrestricted in their
movement in standard animal house cages, whereby the older
rat population had a reduced activity level as compared to
the younger cohort (45). Skeletal muscle samples were
immediately quick-frozen in liquid nitrogen and ground into
a fine powder using a pestle and mortar. For comparative
studies, equal amounts of young adult versus aged muscle
preparations (100 mg wet weight) were used. Muscle powder
was resuspended in 1 ml of lysis buffer, containing 20 mM
Tris, 7 M urea, 2 M thiourea, 65 mM Chaps, 1% (v/v)
Ampholytes pH 3.0-10.0 and 10 mg/ml DTT. In order to
eliminate excessive viscocity due to the presence of large
quantities of DNA, 10 μl of DNase-I (200 units) was added
per 1 ml of lysis buffer (35). In addition, the lysis buffer was
supplemented with a protease inhibitor cocktail (0.2 mM
pefabloc, 1.4 mM pepstatin, 0.15 mM aprotinin, 0.3 mM E-64,
1 mM leupetin, 0.5 mM soybean trypsin inhibitor and 1 mM
EDTA) to avoid proteolytic degradation of sensitive skeletal
muscle proteins (29). Following incubation for 3 h at room
temperature, with gentle vortexing every 10 min for 30 sec,
the suspension was centrifuged at 4˚C for 20 min at 20,000 x g.
The protein-containing middle layer was carefully removed.
Since excess lipids, salts and nucleic acids may interfere with
the proper two-dimensional gel electrophoretic separation of
extracted proteins; these substances were removed prior to
isoelectric focusing by acetone precipitation, as previously
described in detail (35). Precipitated muscle proteins were
resuspended in standard lysis buffer, and the protein
concentration was determined using the 2-D Quant kit.
Two-dimensional gel electrophoresis. The two-dimensional
gel electrophoretic separation of the soluble protein
complement from young adult versus senescent skeletal
muscle was carried out by standard procedures (30,35,42),
using a total protein amount of 400 μg per gel. Using a re-
swelling tray from GE Healthcare, IPG strips pH 3.0-10.0
(linear) were rehydrated for 12 h with 0.45 ml of a buffer
containing 20 mM Tris, 7 M urea, 2 M thiourea, 65 mM
Chaps, 1% (v/v) Ampholytes pH 3.0-10.0 and 10 mg/ml
DTT). As a tracking dye, the buffer was complemented with
0.05% (w/v) Bromophenol blue. Following placement of the
first-dimension strips gel-side up into the Ettan IPGphor
manifold and coverage with 108 ml of dry-strip cover fluid,
protein samples were loaded by aniodic cup loading, and were
then run on the IPGphor IEF system from GE Healthcare.
The following isoelectric focusing running conditions were
used: 120 min at 300 V (step-and-hold), 150 min at 500 V
(step-and-hold), 60 min at 1000 V (gradient), 60 min at 2000 V
(gradient), 60 min at 4000 V (gradient), 60 min at 6000 V
(gradient), 60 min at 8000 V (gradient), 180 min at 500 V
GANNON et al:  PHOSPHOPROTEOMIC ANALYSIS OF AGED SKELETAL MUSCLE34
(step-and-hold) and 120 min at 8000 V (step-and hold).
Following first-dimension separation, gel strips were
equilibrated for 30 min in the above described buffer containing
100 mM dithiothreitol followed by another 30 min of
equilibration with the buffer being supplemented with 0.25 M
ideoacetamide (42). Using the Ettan Dalt-Twelve system
from GE Healthcare, the gel electrophoretic separation of
muscle proteins in the second dimension was performed with
standard 12.5% SDS-PAGE resolving gels (30). Following a
brief washing in SDS-containing running buffer, isoelectric
focusing strips were positioned on top of the second-
dimension slab gel with the help of a 1% (w/v) agarose sealing
gel. Twelve slab gels were run in parallel at 0.5 W/gel for
60 min and then at 15 W/gel for 4.5 h until the blue dye front
had just disappeared from the bottom of the gel.
Pro-Q Diamond gel staining and multiplex image analysis.
Fluorescent staining of slab gels using the Pro-Q Diamond
phosphoprotein gel stain was carried out by an optimized
procedure, which was based on published protocol and the
manufacturer's recommendations (47-51). Gels were fixed
overnight in 50% (v/v) methanol, 10% (v/v) trichloroacetic
acid and then fixed again in a fresh solution for 60 min,
whereby a minimum of 1l fixation solution was used per slab
gel. Following wash steps with four changes of distilled
water for 15 min, gels were incubated in parallel with the
undiluted fluorescent dye for 4 h in the dark. De-staining was
achieved with four successive washes using 4% (w/v)
acetonitrile in 50 mM sodium acetate, pH 4.0. Reproducible
images can be obtained ~4 h after staining. Fluorescently
labeled proteins were visualized using the Typhoon Trio
variable mode imager system from GE Healthcare. Images
were scanned using a 532-nm laser with a PMT value for all
scanned images of 600. Prior to analysis, gel images were
cropped using the Image-Quant TL software programme. All
gels were scanned at 100 mm resolution. Following image
acquisition of Pro-Q Diamond labeled protein spots, slab gels
were stained for total protein with the dye Ruthenium II
Bathophenathroline Disulfonate Chelate (RuBPs), which
permitted direct comparison of the phosphoprotein cohort with
the total muscle protein profile. A stock solution of RuBPs
dye was prepared as described previously by Rabilloud and
co-workers (52). Following two washings for 5 min, gels
were stained for 6 h in 20% (v/v) ethanol containing 200 nM
of ruthenium chelate. Gels were re-equilibrated twice for
10 min in distilled water prior to imaging. Gel analysis was
performed with the Image Master Platinum 5 analysis
software package. Protein spots that showed a drastic increase
or decrease were then identified using mass spectrometric
fingerprinting analysis (20).
Mass spectrometric fingerprinting analysis. The mass
spectrometric identification of skeletal muscle proteins of
interest was performed with colloidal Coomassie-stained
two-dimensional pick gels, matched to the Pro-Q Diamond
labeled master gel. Standard in-gel tryptic digestion was used
for the generation of peptide fingerprints, and matrix-assisted
laser desorption/ionization time-of-flight (MALDI-ToF)
mass spectrometric analysis was performed as previously
optimized by our laboratory (29,35,41,42). Briefly, excised
gel plugs of proteins with a drastic change in expression or
phosphorylation levels were placed in presiliconised plastic
tubes and then destained, desalted and washed by standard
procedures (42). Protein digestion was carried out with 1 mg
of trypsin per 20 ml of 50 mM NH4HCO3. Following an initial
incubation step for 60 min at 37˚C, excess enzyme solution
was removed and 10 μl of 50 mM NH4HCO3 was added to
each gel plug in order to keep gel pieces wet overnight (35).
Peptide mixtures were then centrifuged at 12,000 x g for
10 min, and the resulting supernatant was carefully removed
from each incubation tube and placed into a clean silconised
plastic tube. Extracted solutions were concentrated,
resuspended in 5 μl of 3% (v/v) trifluoroacetic acid and
analysed by MALDI-ToF mass spectrometry (42). Following
desalting, tryptic peptides from individual muscle protein
spots were eluted onto the sample plate with a matrix solution,
consisting of 5 mg/ml α-cyano-4 hydroxycinnamic acid in
50% (v/v) acetonitrile/0.1% (v/v) trifluoroacetic acid.
Recording of mass spectra was conducted with an Amersham
Ettan MALDI-ToF Pro instrument (GE Healthcare) operating
in the positive reflector mode at the following parameters:
accelerating voltage 20 kV; and pulsed extraction: on
(focus mass 2500). For external and internal calibration,
Peptidemix-1 from Laserbiolabs containing peaks ranging
from 1046.5 m/z to 2465.10 m/z and trypsin autolysis peaks
at 221.104 m/z and 842.50 m/z, respectively, were employed
(41). Mass spectra were analyzed with MALDI evaluation
software to identify muscle protein species, using the PMF
ProFound search engine for peptide mass fingerprinting (35).
All certainty hits of rat gastrocnemius muscle proteins
generated by the ProFound search engine were then matched
against the publicly available search engine MASCOT
(http://www.matrixscience.com).
Results
Mapping of high-abundance phosphoproteins in skeletal
muscle using fluorescent two-dimensional phospho-sensitive
ProQ Diamond labeling. Prior to the comparative gel electro-
phoretic analysis of the young adult versus aged skeletal
muscle phosphoproteome, we determined the position of
landmark proteins with a phosphorylation moiety. This
analysis was carried out with the fluorescent phospho-
sensitive ProQ Diamond labeling method (48,49), which has
recently been applied in several large-scale phosphoproteomic
studies (53-55). Fig. 1 shows a cohort of major soluble
phosphoproteins from rat skeletal muscle, stained with
colloidal Coomassie dye, that correlate to ProQ Diamond-
labeled protein species, as shown in Fig. 2. It was possible to
separate well-established skeletal muscle marker proteins
ranging from 16.3 kDa (cytochrome c oxidase) to 128.3 kDa
(myosin protein c) in relative molecular mass and with a pI-
range of an ~pH 4.6 (myosin light chain) to pH 9.4 (malate
dehydrogenase). Labeling of nitrocellulose replicas of identical
slab gels, which had been used for the ProQ Diamond
analysis, with phospho-specific antibodies resulted in a
significantly lower staining intensity (not shown). This
demonstrates the superiority of the fluorescent phospho-
staining method over conventional antibody-based techniques,
as previously discussed (47-51). Importantly, the overall two-
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Figure 2. Comparative two-dimensional gel electrophoretic analysis of the young adult versus the aged phosphoproteome from rat skeletal muscle. Shown are
two-dimensional gels labeled with silver (A and B), the fluorescent phosphoprotein gel stain Pro-Q Diamond (C and D) or the total protein dye Ruthenium II
Bathophenathroline Disulfonate Chelate (RuBPs) (E and F), comparing the protein expression levels between 3-month-old (A, C and E) versus 30-month-old
(B, D and F) skeletal muscle preparations. Isoelectric focusing was carried out on 24-cm pH 3.0-10.0 IPG strips in the first dimension and standard 12.5%
polyacrylamide slab gels in the second dimension. The pH values of the first dimension gel system and molecular mass standards (in kDa) of the second
dimension are indicated on the top and on the left of the panels, respectively.
Figure 1. Two-dimensional gel electrophoretic reference gel of major
phosphoproteins from rat skeletal muscle. Shown is a colloidal Coomassie
Blue (CBB)-stained reference gel of 30-month-old rat skeletal muscle used
for the mass spectrometric identification of proteins labeled by the
fluorescent phosphoprotein-specific ProQ Diamond dye (Fig. 2C and D).
Isoelectric focusing was carried out on 24-cm pH 3.0-10.0 IPG strips in the
first dimension and standard 12.5% polyarcylamide slab gels in the second
dimension. The pH values of the first dimension gel system and molecular
mass standards (in kDa) of the second dimension are indicated on the top
and on the left of the panels, respectively. Identified proteins are marked by
circles and are numbered 1-59. Table I includes a detailed listing of these
landmark phosphoproteins from skeletal muscle.
dimensional protein spot pattern of rat muscle shown in the
reference gel of Fig. 1 was found to be comparable to previous
studies on the electrophoretic separation of total skeletal
muscle extracts. Recent reports by various proteomics research
groups focusing on contractile tissue, such as Yan et al (24),
Gelfi et al (27), Piec et al (39) and Doran et al (42) provide the
established slab gel patterns of skeletal muscle. Following
successful electrophoretic separation and ProQ Diamond
labeling, abundant skeletal muscle phosphoproteins were
unequivocally identified by peptide mass fingerprint analysis,
using MALDI-ToF mass spectrometric screening of tryptic
in-gel digests.
Identification of phosphoprotein species in skeletal muscle.
As listed in Table I, fluorescent ProQ Diamond labeling
identified 59 muscle phosphoprotein species that formed
characteristic two-dimensional landmark spots (Fig. 1). This
included major elements of the contractile apparatus (myosin
heavy chain, 103.9 kDa/pI 5.3; myosin light chain MLC1,
20.8 kDa/pI 5.0; MLC2, 18.9 kDa/pI 4.8; MLC3, 16.7 kDa/
pI 4.6; actin, 42.4 kDa/pH 5.2) and its regulatory machinery
(tropomyosin, 33.0 kDa/pI 4.6). Major phosphorylated
muscle proteins also belonged to the class of key metabolic
enzymes involved in glycolysis (pyruvate kinase, 58.3 kDa/
pI 6.6; enolase, 47.4 kDa/pI 6.2; aldolase, 39.8 kDa/pI 8.9;
lactate dehydrogenase, 30.0 kDa/pI 9.4; phosphoglycerate
mutase, 28.9 kDa/pI 9.0; triosephosphate isomerase, 27.2 kDa/
pI 7.1); the citric acid cycle (aconitase, 86.2 kDa/pI 8.2;
malate dehydrogenase, 36.6 kDa/pI 5.9); oxidative
phosphorylation (ATP synthase, 51.2 kDa/pI 4.9; F1-ATPase,
55.4 kDa/pI 8.4; cytochrome c oxidase, 16.3 kDa/pI 6.1);
carbon dioxide removal (carbonic anhydrase, 29.7 kDa/pI 6.5)
and nucleotide metabolism (creatine kinase, 43.2 kDa/pI 6.6;
adenylate kinase, 21.6 kDa/pI 7.7). Landmark phosphoproteins
are furthermore represented by transporters (transferrin,
78.6 kDa/pI 7.0; albumin, 70.7 kDa/pI 6.1; phosphatidyl-
ethanolamine binding protein, 20.9 kDa/pI 5.5); cytoskeletal
elements (desmin, 53.5 kDa/pI 5.2); ion handling proteins
(voltage dependent anion channel, 32.7 kDa/pI 8.5) and stress
proteins (Hsp72, 71.1 kDa,/pI 5.4; Hsp27, 22.9 kDa/pI 6.1;
αB crystallin, 20.1 kDa/pI 6.8). 
Quantitative changes in the phosphoproteome of aged skeletal
muscle. Following the establishment of a phosphoprotein
reference map for rat skeletal muscle, comparative fluorescent
dye staining was carried out to determine potential differences
in young adult versus senescent fibres. Fig. 2 shows that the
overall protein expression pattern is relatively comparable
between 3-month- and 30-month-old gastrocnemius muscle.
Both silver staining (Fig. 2A and B) and fluorescent RuBPs
labeling (E and F) illustrates that most soluble muscle
proteins do not exhibit massive alterations in their abundance
during fibre aging. In contrast, fluorescent phospho-specific
labeling, as illustrated by the representative gels shown in
Fig. 2C and D, showed significant differences between the
two muscle complements studied. Fig. 3 displays the
phosphoproteins with an altered level of this post-translational
modification as compared to the total cohort of ProQ
Diamond-labeled muscle proteins. The phospho-specific
survey revealed that 22 muscle protein spots exhibit a
differential expression pattern between 3-month- and 30-
month-old gastrocnemius fibres. As listed in Table II,
increased phosphorylation levels were observed for myosin
light chain 2, golgi reassembly stacking protein 1, tropo-
myosin α, lactate dehydrogenase, desmin, actin, albumin,
Down syndrome critical region homolog 6 protein and
aconitase, as well as 4 unidentified proteins. The fold change
in phosphorylation was clearly higher for protein spot 1, the
myosin light chain isoform MLC-2, as compared to its
increase in protein abundance. In contrast, decreased ProQ
Diamond binding was shown for cytochrome c oxidase,
creatine kinase and enolase, as well as 4 unidentified muscle
components. However, direct comparison between altered
phosphorylation levels and modified protein abundance of
individual protein species, as listed in Table II, revealed that
these two parameters do not necessarily correlate for all
proteins during the muscle aging process. While the majority
of muscle proteins with a decreased ProQ Diamond binding
also showed a lower level of protein density, one of the
unidentified proteins, spot 15 in Fig. 3, exhibited increased
protein levels. Overall, the phospho-specific labeling
procedure indicates that numerous skeletal muscle proteins
are modified by a drastic age-dependent alteration in
phosphorylation. 
Discussion
Aged skeletal muscle proteins undergo considerable changes
in post-translational modifications, as recently reviewed by
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Figure 3. Two-dimensional gel electrophoretic master map of the aged
skeletal muscle phosphoproteome. Shown is a two-dimensional master gel
of the aged gastrocnemius muscle phosphoproteome, stained with the
fluorescent phosphosprotein gel stain Pro-Q Diamond. Distinct two-
dimensional protein spots are marked by green borders and muscle phospho-
proteins that exhibited significant changes in their abundance are indicated
with red borders. Phosphoproteins with a drastically altered abundance,
which have been identified by peptide mass fingerprinting analysis, are
numbered 1-22, and are listed in Table II. Isoelectric focusing has been
carried out on 24-cm pH 3.0-10.0 IPG strips in the first dimension and
standard 12.5% polyarcylamide slab gels in the second dimension. The pH
values of the first dimension gel system and molecular mass standards (in
kDa) of the second dimension are indicated on the top and on the left of the
panels, respectively.
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Table I. Colloidal Coomassie-stained reference 2-D map of phosphorylated proteins from 30-month-old rat muscle.a
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Spot no. Name of identified proteins Sequence Molecular pI Expectation Protein 
coverage (%) mass (kDa) value accession no.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
1 Muscle myosin heavy chain 16.0 103.9 5.3 6.5e-003 gi[71143152]
2 Myosin protein c, fast-type 27.4 128.3 6.2 1e-004 gi[62639660]
3 Serotransferrin precursor 19.3 78.6 7.0 1e-004 gi[6175089]
4 Serotransferrin precursor 11.7 78.6 7.0 1e-004 gi[6175089]
5 Transferrin 12.0 78.6 7.0 0.030 gi[1854476]
6 Aconitase 2, mitochondrial 20.3 86.2 8.2 1e-004 gi[38541404]
7 Hsp72-ps1 17.0 71.1 5.4 4.9e-003 gi[347019]
8 Albumin 28.0 70.7 6.1 2.2e-006 gi[19705431]
9 Albumin 22.0 70.7 6.1 8.8e-004 gi[55391508]
10 Albumin 35.0 70.7 6.1 2.5e-006 gi[55391508]
11 Desmin 16.0 53.5 5.2 1e-004 gi[11968118]
12 Desmin 21.7 53.5 5.2 1e-004 gi[11968118]
13 Pyruvate kinase 29.0 58.3 6.6 0.011 gi[16757994]
14 ATP synthase, ß subunit 29.7 51.2 4.9 1e-004 gi[1374715]
15 Enolase 1, α 25.0 47.4 6.2 0.021 gi[6978809]
16 α1 actin, skeletal muscle 21.0 42.4 5.2 0.057 gi[54036667]
17 α actin 21.0 42.4 5.2 2.3e-004 gi[54036667]
18 α actin (aa27-375) 15.8 39.5 5.8 1e-004 gi[49871]
19 Hemogen 20.0 54.1 5.4 0.070 gi[19882215]
20 Enolase 3, ß 36.0 47.3 7.1 3.7e-004 gi[54035288]
21 Enolase 3, ß 35.0 47.3 7.1 4.8e-003 gi[54035288]
22 F1 ATPase, chain A 23.0 55.4 8.4 7.9e-003 gi[6729934]
23 Creatine kinase 24.0 33.4 8.0 2.3e-003 gi[203480]
24 Creatine kinase, chain M 28.0 43.2 6.6 4.8e-004 gi[6978661]
25 Creatine kinase, mitochondrial 21.0 47.8 9.2 0.075 gi[125313]
26 Tropomyosin 1 24.0 33.0 4.6 1.8e-004 gi[207498]
27 Creatine kinase 33.0 43.3 6.6 1.6e-004 gi[38541353]
28 Aldolase A 30.0 39.8 8.9 0.015 gi[3978487]
29 Aldolase A 30.0 39.8 8.9 5.7e-004 gi[3978487]
30 Tropomyosin α 17.0 32.7 4.7 1e-004 gi[207349]
31 Golgi reassembly stacking protein 1 7.0 48.1 4.6 0.032 gi[9506751]
32 Protein phosphatase 1H 18.0 19.4 5.7 0.025 gi[56789214]
33 Lactate dehydrogenase 16.0 36.9 5.7 0.016 gi[6981146]
34 Malate dehydrogenase 21.0 36.6 6.2 1e-004 gi[15100179]
35 Malate dehydrogenase 26.9 36.6 5.9 1.9e-003 gi[37590235]
36 Lactate dehydrogenase A 24.0 30.0 9.4 1e-004 gi[38014570]
37 Voltage dependent anion channel 32.9 32.7 8.5 1e-004 gi[4105605]
38 Malate dehydrogenase 24.0 36.1 9.4 1.2e-003 gi[42476181]
39 CD3 antigen δ polypeptide 25.0 19.6 5.9 0.042 gi[7709998]
40 Carbonic anhydrase, CA3 28.0 29.7 6.5 1e-004 gi[203225]
41 Carbonic anhydrase, CA3 53.5 29.7 6.9 1e-004 gi[31377484]
42 Phospho glycerate mutase 2 34.0 28.9 9.0 3.8e-005 gi[8393948]
43 Myosin, light polypeptide 3 43.0 22.3 5.0 8.8e-004 gi[6981240]
44 Down syndrome critical region homolog 6 26.0 23.3 5.7 0.039 gi[34865391]
45 Hsp27 30.0 22.9 6.1 1e-004 gi[8248633]
46 Myosin light chain 1, slow 19.0 27.7 5.8 0.073 gi[34880612]
47 Triosephosphate isomerase 1 33.5 27.2 7.1 1e-004 gi[38512111]
48 Triosephosphate isomerase 1 33.5 27.2 7.1 1.4e-004 gi[38512111]
49 Triosephosphate isomerase 1 33.5 27.2 7.1 1e-004 gi[38512111]
50 Myosin light chain 1 32.8 20.8 5.0 1e-004 gi[127131]
Schoneich (56). For example, the nitration of protein tyrosine
residues represents an important post-translational modifi-
cation during biological aging (44). This has been especially
well documented for the sarcoplasmic reticulum Ca2+-
ATPase (57) and glycogen phosphorylase b (58). Reduced
activity of the SERCA-type Ca2+-pump as a result of the
nitration of selected tyrosines appears to play a key role in the
pathophysiological increase in intracellular Ca2+ levels within
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE  22:  33-42,  2008 39
Table I. Continued.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Spot no. Name of identified proteins Sequence Molecular pI Expectation Protein 
coverage (%) mass (kDa) value accession no.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
51 Myosin light chain 1 27.0 20.8 5.0 0.015 gi[127131]
52 Myosin light chain 3f, fast 27.0 16.7 4.6 1e-004 gi[13487933]
53 Phosphatidylethanolamine binding protein 26.0 20.9 5.5 0.016 gi[8393910]
54 αB Crystallin 45.0 20.1 6.8 0.042 gi[16905067]
55 Adenylate kinase 51.0 21.6 7.7 1.8e-004 gi[8918488]
56 Cytochrome c oxidase, subunit Va 41.0 16.3 6.1 0.079 gi[24233541]
57 Cytochrome c oxidase, subunit Va 41.0 16.3 6.1 0.042 gi[24233541]
58 Myosin light chain 2 38.0 18.9 4.8 0.052 gi[127167]
59 Myosin light chain 2 40.0 19.1 4.8 0.011 gi[6981238]
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
aSkeletal muscle phosphoproteins were localized with the fluorescent phospo-specific Pro-Q Diamond dye and then identified in an identical
Coomassie-labeled 2-D gel by MALDI-ToF MS analysis.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Table II. List of muscle proteins that exhibit a drastic age-dependent change in phosphorylation as judged by fluorescent
phospo-specific Pro-Q Diamond labeling.a
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Spot no. Name of identified proteins Protein accession no. Phosphorylation Protein fold 
fold change (+/-) change (+/-)
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
1 Myosin light chain 2 gi[6981238] +28.48 +9.15
2 Unidentified - +5.12 n.d.
3 Golgi reassembly stacking protein 1 gi[9506751] +5.58 n.d.
4 Tropomyosin, α gi[207349] +2.50 n.d.
5 Lactate dehydrogenase gi[6981146] +2.41 n.d.
6 Unidentified - +2.30 n.d.
7 Desmin gi[11968118] +2.22 +2.09
8 Actin, α1 gi[9506371] +2.18 +2.73
9 Albumin gi[55391508] +2.10 n.d.
10 Down sydrome critical region homolog 6 gi[34865391] +2.09 n.d.
11 Actin, α gi[54036667] +2.07 n.d.
12 Unidentified - +1.97 +1.95
13 Aconitase 2 gi[38541404] +1.80 n.d.
14 Unidentified - +1.50 n.d.
15 Unidentified - -1.57 +1.77
16 Unidentified - -1.70 n.d.
17 Cytochrome c oxidase gi[24233541] -1.89 n.d.
18 Cytochrome c oxidase gi[24233541] -2.05 n.d.
19 Creatine kinase gi[38541353] -2.25 n.d.
20 Enolase 3, ß gi[54035288] -2.50 -2.50
21 Unidentified - -3.52 -2.03
22 Unidentified - -5.75 n.d.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
aThe young adult (3-month-old) versus senescent (30-month-old) rat skeletal muscle proteome was differentially labeled with the fluorescent
phospo-specific Pro-Q Diamond dye and the protein stain RuBPS, followed by the identification of proteins with a drastic change in
phosphorylation by MALDI-ToF MS analysis (n.d., not detectable).
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
senescent skeletal muscle fibres (59). Comprehensive
proteomic studies by Kanski et al (44,60) have identified an
age-related increase in the nitration of numerous other skeletal
muscle proteins. This includes enolase, aldolase, creatine
kinase, tropomyosin, glyceraldehyde-3-phosphate dehydro-
genase, myosin light chain, pyruvate kinase, actinin, actin and
the ryanodine receptor. The nitration of these essential muscle
proteins may therefore be a significant factor responsible for
the age-related decline in muscle strength (56).
In analogy to these studies on age-related post-translational
modifications, we used here gel electrophoretic separation,
labeling with phospho-specific fluorescent Pro-Q Diamond
stain and mass spectrometric analysis to identify muscle
proteins with an altered phosphorylation pattern. Reversible
protein phosphorylation plays a central role in the activity,
regulation, structure and localization of proteins (18). It is
estimated that more than one-third of the proteome of a typical
mammalian cell is phosphorylated (13). Since skeletal
muscle aging is associated with a drastic decline in muscle
mass and strength (38), it was of interest to determine whether
the overall phosphorylation levels of the soluble muscle
proteome were altered by the aging process. Comparative
phospho-specific dye staining of two-dimensional gels
representing young adult versus senescent muscle revealed
that a small number of muscle proteins appear to be altered
with respect to their phosphorylation levels. 
The most drastic increase in phosphorylation occurred in
the contractile element MLC2. In addition, actin and
tropomyosin also showed increased phosphorylation levels.
Transitions in fibre types are associated with major changes
in the abundance and isoform expression pattern of both
myosin light and heavy chains (61,62). The results from a
recent proteomic study using fluorescent difference in-gel
electrophoresis agree with the protein analysis presented here
and have also shown an increased density of the MLC2 form
of the myosin light chain in aged rat gastrocnemius muscle
(42). It has previously been documented that the natural aging
process influences fibre type proportions, fibre size and
contractile properties (63). In aged rat skeletal muscle, the loss
of whole motor units causes a decrease in the overall number
of fibres (64), and cycles of denervation and reinnervation
lead to the incomplete recruitment of senescent fibres (65).
Thus, altered expression levels and/or post-translational
modifications in contractile proteins are an indication that
aged motor units exhibit severely altered physiological
properties. Cutlip and co-workers (66) have demonstrated
that age impairs the ability of rat muscle to properly adapt to
repetitive mechanical loading, which agrees with the idea
that aged skeletal muscles have a reduced speed of contraction
(38,64). The altered phosphorylation of the fatty acid binding-
protein albumin, the glycolytic enzymes lactate dehydro-
genase and enolase, as well as the citric acid cycle component
aconitase and the mitochondrial cytochrome c oxidase may
reflect changed activities of these important metabolic
components in aged fibres. Changed post-translational
modifications agree with previous proteomic investigations
of skeletal muscle aging, which have clearly indicated a shift
to more oxidative-aerobic metabolism in slower-contracting
senescent fibres (39-42). In addition, changed phosphorylation
of creatine kinase and desmin indicate age-related modifications
of nucleotide metabolism and the cytoskeletal network of
skeletal muscle, respectively. Creatine kinase has previously
been shown to be affected in sarcopenia of old age (42), and
its altered post-translational modifications indicate changes
in the bioenergetic shuttle system of creatine phosphate units.   
In conclusion, aging-induced alterations in phospho-
proteins appear mostly to affect the contractile machinery, as
well as enzymes associated with cytosolic and mitochondrial
metabolism. Changed post-translational modifications, in
addition to impaired protein synthesis rates, may play an
important pathobiochemical role in sarcopenia. The underlying
mechanisms of age-related muscle degeneration appear to be
multi-factorial, but impaired protein function is of central
importance for fibre wasting. It remains to be elucidated
whether the main triggering factor of sarcopenia is represented
by denervation or resides in the muscle tissue itself. However,
it is clear that muscle aging is associated with distinct changes
in one of the most important post-translational modifications
found in mammalian systems, phosphorylation on tyrosine,
threonine and serine residues, as shown in this study.
Acknowledgements
Research was supported by a principal investigator grant
from Science Foundation Ireland (SFI-04/IN3/B614) and
equipment grants were from the Irish Health Research
Board (HRB-EQ/2003/3, HRB-EQ/2004/2). The authors thank
Dr Marina Lynch (Department of Physiology, Trinity College,
Dublin) for her generous help obtaining young adult and
aged rat muscle.
References
1. Black DL: Protein diversity from alternative splicing: a challenge
for bioinformatics and post-genome biology. Cell 103: 367-370,
2000.
2. de Hoog CL and Mann M: Proteomics. Annu Rev Genomics
Hum Genet 5: 267-293, 2004.
3. Cox J and Mann M: Is proteomics the new genomics? Cell 130:
395-398, 2007.
4. Cho WC: Proteomics technologies and challenges. Genomics
Proteomics Bioinformatics 5: 77-85, 2007.
5. Mann M and Jensen ON: Proteomic analysis of post-
translational modifications. Nat Biotechnol 21: 255-261, 2003. 
6. Seo J and Lee KJ: Post-translational modifications and their
biological functions: proteomic analysis and systematic
approaches. J Biochem Mol Biol 37: 35-44, 2004. 
7. Jensen ON: Modification-specific proteomics: characterization
of post-translational modifications by mass spectrometry. Curr
Opin Chem Biol 8: 33-41, 2004.
8. Kalume DE, Molina H and Pandey A: Tackling the phospho-
proteome: tools and strategies. Curr Opin Chem Biol 7: 64-69,
2003. 
9. Reinders J and Sickmann A: State-of-the-art in phospho-
proteomics. Proteomics 5: 4052-4061, 2005. 
10. Salih E: Phosphoproteomics by mass spectrometry and classical
protein chemistry approaches. Mass Spectrom Rev 24: 828-846,
2005.
11. Garcia BA, Shabanowitz J and Hunt DF: Analysis of protein
phosphorylation by mass spectrometry. Methods 35: 256-264,
2005. 
12. Goshe MB: Characterizing phosphoproteins and phospho-
proteomes using mass spectrometry. Brief Funct Genomic
Proteomic 4: 363-376, 2006. 
13. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P
and Mann M: Global, in vivo, and site-specific phosphorylation
dynamics in signaling networks. Cell 127: 635-648, 2006.
14. Sickmann A and Meyer HE: Phosphoamino acid analysis.
Proteomics 1: 200-206, 2001.
GANNON et al:  PHOSPHOPROTEOMIC ANALYSIS OF AGED SKELETAL MUSCLE40
15. Manning G, Whyte DB, Martinez R, Hunter T and Sudarsanam S:
The protein kinase complement of the human genome. Science
298: 1912-1934, 2002.
16. Moorhead GB, Trinkle-Mulcahy L and Ulke-Lemee A:
Emerging roles of nuclear protein phosphatases. Nat Rev Mol
Cell Biol 8: 234-244, 2007. 
17. Cohen P: The regulation of protein function by multisite
phosphorylation - a 25 year update. Trends Biochem Sci 25:
596-601, 2000. 
18. Cohen P: The origins of protein phosphorylation. Nat Cell Biol
4: E127-E130, 2002. 
19. Isfort RJ: Proteomic analysis of striated muscle. J Chromatogr
B771: 155-165, 2002.
20. Doran P, Donoghue P, O'Connell K, Gannon J and Ohlendieck K:
Proteomic profiling of pathological and aged skeletal muscle
fibres by peptide mass fingerprinting (Review). Int J Mol Med
19: 547-564, 2007.
21. Doran P, Gannon J, O'Connell K and Ohlendieck K: Proteomic
profiling of animal models mimicking skeletal muscle disorders.
Proteomics Clin Appl 1: 1169-1184, 2007.
22. Gelfi C, De Palma S, Cerretelli P, Begum S and Wait R: Two-
dimensional protein map of human vastus lateralis muscle.
Electrophoresis 24: 286-295, 2003. 
23. Capitanio D, Vigano A, Ricci E, Cerretelli P, Wait R and Gelfi C:
Comparison of protein expression in human deltoideus and vastus
lateralis muscles using two-dimensional gel electrophoresis.
Proteomics 5: 2577-2586, 2005.
24. Yan JX, Harry RA, Wait R, Welson SY, Emery PW, Preedy VR
and Dunn MJ: Separation and identification of rat skeletal muscle
proteins using two-dimensional gel electrophoresis and mass
spectrometry. Proteomics 1: 424-434, 2001.
25. Sanchez JC, Chiappe D, Converset V, Hoogland C, Binz PA,
Paesano S, Appel RD, Wang S, Sennitt M, Nolan A, Cawthorne MA
and Hochstrasser DF: The mouse SWISS-2DPAGE database: a
tool for proteomics study of diabetes and obesity. Proteomics 1:
136-163, 2001.
26. Okumura N, Hashida-Okumura A, Kita K, Matsubae M,
Takao T and Nagai K: Proteomic analysis of slow- and fast-
twitch skeletal muscles. Proteomics 5: 2896-2906, 2005.
27. Gelfi C, Vigano A, De Palma S, Ripamonti M, Begum S,
Cerretelli P and Wait R: 2-D protein maps of rat gastrocnemius
and soleus muscles: a tool for muscle plasticity assessment.
Proteomics 6: 321-340, 2006.
28. Bihan MC, Hou Y, Harris N, Tarelli E and Coulton GR:
Proteomic analysis of fast and slow muscles from normal and
kyphoscoliotic mice using protein arrays, 2-DE and MS.
Proteomics 6: 4646-4661, 2006. 
29. Donoghue P, Doran P, Dowling P and Ohlendieck K:
Differential expression of the fast skeletal muscle proteome
following chronic low-frequency stimulation. Biochim Biophys
Acta 1752: 166-176, 2005.
30. Donoghue P, Doran P, Wynne K, Pedersen K, Dunn MJ and
Ohlendieck K: Proteomic profiling of chronic low-frequency
stimulated fast muscle. Proteomics 7: 3417-3430, 2007.
31. Kislinger T, Gramolini AO, Pan Y, Rahman K, MacLennan DH
and Emili A: Proteome dynamics during C2C12 myoblast
differentiation. Mol Cell Proteomics 4: 887-901, 2005. 
32. Doherty MK, McLean L, Hayter JR, Pratt JM, Robertson DH,
El-Shafei A, Gaskell SJ and Beynon RJ: The proteome of chicken
skeletal muscle: changes in soluble protein expression during
growth in a layer strain. Proteomics 4: 2082-2093, 2004.
33. Bouley J, Meunier B, Chambon C, De Smet S, Hocquette JF
and Picard B: Proteomic analysis of bovine skeletal muscle
hypertrophy. Proteomics 5: 490-500, 2005.
34. Ge Y, Molloy MP, Chamberlain JS and Andrews PC: Proteomic
analysis of mdx skeletal muscle: great reduction of adenylate
kinase 1 expression and enzymatic activity. Proteomics 3:
1895-1903, 2003.
35. Doran P, Martin G, Dowling P, Jockusch H and Ohlendieck K:
Proteome analysis of the dystrophin-deficient MDX diaphragm
reveals a drastic increase in the heat shock protein cvHSP.
Proteomics 6: 4610-4621, 2006. 
36. De Palma S, Morandi L, Mariani E, Begum S, Cerretelli P, Wait R
and Gelfi C: Proteomic investigation of the molecular
pathophysiology of dysferlinopathy. Proteomics 6: 379-385,
2006.
37. Isfort RJ, Wang F, Greis KD, Sun Y, Keough TW, Farrar RP,
Bodine SC and Anderson NL: Proteomic analysis of rat soleus
muscle undergoing hindlimb suspension-induced atrophy and
reweighting hypertrophy. Proteomics 2: 543-550, 2002.
38. Edstrom E, Altun M, Bergman E, Johnson H, Kullberg S,
Ramirez-Leon V and Ulfhake B: Factors contributing to neuro-
muscular impairment and sarcopenia during aging. Physiol
Behav 92: 129-135, 2007. 
39. Piec I, Listrat A, Alliot J, Chambon C, Taylor RG and Bechet D:
Differential proteome analysis of aging in rat skeletal muscle.
FASEB J 19: 1143-1145, 2005. 
40. Gelfi C, Vigano A, Ripamonti M, Pontoglio A, Begum S,
Pellegrino MA, Grassi B, Bottinelli R, Wait R and Cerretelli C:
The human muscle proteome in aging. J Proteome Res 5:
1344-1353, 2006.
41. O'Connell K, Gannon J, Doran P and Ohlendieck K: Proteomic
profiling reveals a severely perturbed protein expression pattern
in aged skeletal muscle. Int J Mol Med 20: 145-153, 2007.
42. Doran P, O'Connell K, Gannon J, Kavanagh M and Ohlendieck K:
Opposite pathobiochemical fate of pyruvate kinase and adenylate
kinase in aged rat skeletal muscle as revealed by proteomic
DIGE analysis. Proteomics 8: 364-377, 2008. 
43. Cobon GS, Verrills N, Papakostopoulos P, Eastwood H and
Linnane AWN: The proteomics of ageing. Biogerontology 3:
133-136, 2002.
44. Kanski J, Alterman MA and Schoneich C: Proteomic
identification of age-dependent protein nitration in rat skeletal
muscle. Free Radic Biol Med 35: 1229-1239, 2003.
45. Doran P, Gannon J, O'Connell K and Ohlendieck K: Aging
skeletal muscle shows a drastic increase in the small heat shock
proteins αB-crystallin/HspB5 and cvHsp/HspB7. Eur J Cell Biol
86: 629-640, 2007.
46. Nishimura RN and Sharp FR: Heat shock proteins and neuro-
muscular disease. Muscle Nerve 32: 693-709, 2005. 
47. Steinberg TH, Agnew BJ, Gee KR, Leung WY, Goodman T,
Schulenberg B, Hendrickson J, Beechem JM, Haugland RP and
Patton WF: Global quantitative phosphoprotein analysis using
multiplexed proteomics technology: Proteomics 3: 1128-1144,
2003. 
48. Goodman T, Schulenberg B, Steinberg TH and Patton WF:
Detection of phosphoproteins on electroblot membranes using a
small-molecule organic fluorophore. Electrophoresis 25:
2533-2538, 2004. 
49. Schulenberg B, Goodman TN, Aggeler R, Capaldi RA and
Patton WF: Characterization of dynamic and steady-state protein
phosphorylation using a fluorescent phosphoprotein gel stain
and mass spectrometry. Electrophoresis 25: 2526-2532, 2004.
50. Wu J, Lenchik NJ, Pabst MJ, Solomon SS, Shull J and Gerling IC:
Functional characterization of two-dimensional gel-separated
proteins using sequential staining. Electrophoresis 26: 225-237,
2005. 
51. Stasyk T, Morandell S, Bakry R, Feuerstein I, Huck CW,
Stecher G, Bonn GK and Huber LA: Quantitative detection of
phosphoproteins by combination of two-dimensional difference
gel electrophoresis and phosphospecific fluorescent staining.
Electrophoresis 26: 2850-2854, 2005.
52. Rabilloud T, Strub JM, Luche S, van Dorsselaer A and Lunardi J:
A comparison between Sypro Ruby and ruthenium II tris
(bathophenanthroline disulfonate) as fluorescent stains for
protein detection in gels. Proteomics 1: 699-704, 2001. 
53. Liu J, Cai Y, Wang J, Zhou Q, Yang B, Lu Z, Jiao L, Zhang D,
Sui S, Jiang Y, Ying W and Qian X: Phosphoproteome profile of
human liver Chang's cell based on 2-DE with fluorescence
staining and MALDI-ToF/ToF-MS. Electrophoresis 28:
4348-4358, 2007. 
54. Eymann C, Becher D, Bernhardt J, Gronau K, Klutzny A and
Hecker M: Dynamics of protein phosphorylation on Ser/Thr/Tyr
in Bacillus subtilis. Proteomics 7: 3509-3526, 2007. 
55. Kang TH, Bae KH, Yu MJ, Kim WK, Hwang HR, Jung H,
Lee PY, Kang S, Yoon TS, Park SG, Ryu SE and Lee SC:
Phosphoproteomic analysis of neuronal cell death by glutamate-
induced oxidative stress. Proteomics 7: 2624-2635, 2007. 
56. Schoneich C: Protein modification in aging: an update. Exp
Gerontol 41: 807-812, 2006. 
57. Sharov VS, Dremina ES, Galeva NA, Williams TD and
Schoneich C: Quantitative mapping of oxidation-sensitive
cysteine residues in SERCA in vivo and in vitro by HPLC-
electrospray-tandem MS: selective protein oxidation during
biological aging. Biochem J 394: 605-615, 2006. 
58. Sharov VS, Galeva NA, Kanski J, Williams TD and Schoneich C:
Age-associated tyrosine nitration of rat skeletal muscle
glycogen phosphorylase b: characterization by HPLC-nano-
electrospray-tandem mass spectrometry. Exp Gerontol 41:
407-416, 2006. 
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE  22:  33-42,  2008 41
59. Squier TS and Bigelow DJ: Protein oxidation and age-
dependent alterations in calcium homeostasis. Front Biosci 5:
504-526, 2000.
60. Kanski J, Hong SJ and Schoneich C: Proteomic analysis of
protein nitration in aging skeletal muscle and identification of
nitrotyrosine-containing sequences in vivo by nanoelectrospray
ionization tandem mass spectrometry. J Biol Chem 280:
24261-24266, 2005. 
61. Kirschbaum BJ, Heilig A, Hartner KT and Pette D: Electro-
stimulation-induced fast-to-slow transitions of myosin light and
heavy chains in rabbit fast-twitch muscle at the mRNA level.
FEBS Lett 243: 123-126, 1989.
62. Gonzalez B, Negredo P, Hernando R and Manso R: Protein
variants of skeletal muscle regulatory myosin light chain
isoforms: prevalence in mammals, generation and transitions
during muscle remodeling. Pflugers Arch 443: 377-386, 2002.
63. Larsson L and Edstrom L: Effects of age on enzyme-histo-
chemical fibre spectra and contractile properties of fast- and
slow-twitch skeletal muscles in the rat. J Neurol Sci 76: 69-89,
1986. 
64. Edstrom L and Larsson L: Effects of age on contractile and
enzyme-histochemical properties of fast- and slow-twitch single
motor units in the rat. J Physiol 392: 129-145, 1987.
65. Larsson L, Ansved T, Edstrom L, Gorza L and Schiaffino S:
Effects of age on physiological, immunohistochemical and
biochemical properties of fast-twitch single motor units in the
rat. J Physiol 443: 257-275, 1991. 
66. Cutlip RG, Baker BA, Geronilla KB, Kashon ML and Wu JZ:
The influence of velocity of stretch and dash shortening
contractions on muscle performance during chronic exposure:
age effects. Appl Physiol Nutr Metab 32: 443-453, 2007.
GANNON et al:  PHOSPHOPROTEOMIC ANALYSIS OF AGED SKELETAL MUSCLE42
